Sector Chart Celldex Therapeutics, Inc.

Stocks

CLDX

US15117B2025

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-20 EDT			5-day change	1st Jan Change
35.42 ^USD	+0.20%		-8.07%	+30.41%

07-15	Celldex Therapeutics, Inc. Announces Retirement of Sam Martin from Senior Vice President, Effective on or About March 31, 2027	CI
07-15	Celldex Therapeutics, Inc. Announces Retirement of Sam Martin as Chief Financial Officer, Effective on or About March 31, 2027	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
CELLDEX THERAPEUTICS, INC.	2.78B					-
LONZA GROUP AG	48.71B
REVOLUTION MEDICINES, INC.	38.35B	-	-	-	-	-
BEONE MEDICINES AG	34.53B
IQVIA HOLDINGS INC.	34.03B
CELLTRION, INC.	26.77B